A new therapeutic target in pulmonary hypertension is identified in an experimental model
Researchers at the hospital Clínic Barcelona-IDIBAPS and CIBERES show that the inhibition of survivin, an anti-apoptotic protein, improves pulmonar...
Researchers at the hospital Clínic Barcelona-IDIBAPS and CIBERES show that the inhibition of survivin, an anti-apoptotic protein, improves pulmonar...
Led by researchers from Clínic-IDIBAPS with support from Fundació "la Caixa", the study shows that pregnant women who follow a Mediterranean diet h...
From 3 to 7 July, Arnau Guerrero and Meritxell Solana, two students who won the Extraordinary Baccalaureate Award for the 2021-2022 academic year,...
The study, led by researchers from Clínic-IDIBAPS and CIBER, reveals new functions of TCF20, beyond its role in neurologic processes and its implic...
Pau Sancho-Bru and his team lead the study that links CXCR4 with the process of dedifferentiation of hepatocytes and tissue damage.
The period for submitting applications for the fellowship, which will last two years, from 2024 to 2026, is now open. Francesc Valldeoriola, a neur...
Led by researchers from IDIBAPS-Hospital Clínic Barcelona, the study shows that the technique can be a safe and effective alternative for complex c...
The candidature of the Clínic-IDIBAPS researcher was approved with 90% of the votes at the general assembly of the European Association for the Stu...
They are the Translational cancer research program, the Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience program and the L...